VERONIKA BRYANT: Open Payments
NPI 1053841163 · VERNON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$327 in 12 payments from 8 companies in 2025. Trend: 2023 $523 · 2024 $167 · 2025 $327
Food & beverage: $327
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 3 | $119 |
| Ascensia Diabetes Care Us Inc. | 3 | $67 |
| AstraZeneca Pharmaceuticals LP | 1 | $48 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $25 |
| ABBVIE INC. | 1 | $24 |
| Novo Nordisk Inc | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $13 |
Products named: Korlym, BREZTRI, NEFFY, VRAYLAR, Ozempic, Qelbree, REXULTI.
Industry payments across TX — which companies pay providers there.
